Form 8-K · Current Report · Filed 2025-01-13
Waters Corporation to Present at J.P. Morgan Healthcare Conference
Waters Corporation announced that it will present at the J.P.
- Filer
- Waters Corporation WAT · NYSE
- Filed
- Accession
- 0001193125-25-005378
- CIK
- 0001000697
- Signal
- Low impactHealthcare
- Source
- Official filing on sec.gov ↗
Details
Morgan Healthcare Conference on January 13, 2025, where it will discuss its business performance, growth strategy, and financial results. An investor presentation will be furnished as Exhibit 99.1 and will be available on the company's website.
Items reported
Regulation FD Disclosure
Financial Statements and Exhibits
Market reaction
Close before filing
$380.35
Next session
+6.5%
Since filing
-0.8%
Latest close
$377.31
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from WAT reporting the same item, with the next session's move:
Exhibits (1)
About Waters Corporation
Waters Corporation is a leading entity in the field of analytical instruments and software. It primarily focuses on providing laboratory solutions for a variety of sectors, including pharmaceuticals, healthcare, food and beverage, and chemical analysis. The company's offerings include high-performance liquid chromatography, mass spectrometry systems, and various supporting technologies used for advanced research in life sciences. Waters Corporation is pivotal in enhancing laboratory productivity, offering cutting-edge research tools that assist in drug development, quality control, and environmental testing. Operating globally, it serves a wide array of clients, including academic institutions, government agencies, and private industry players. With its commitment to innovation and precision, Waters Corporation plays a crucial role in advancing scientific and technological progress in multiple critical industries worldwide.
Never miss another WAT filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.